tiprankstipranks

Coherus Biosciences price target lowered to $13 from $20 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Coherus Biosciences to $13 from $20 and keeps a Buy rating on the shares. The anlayst is taking a more conservative view on toripalimab’s launch into new indications.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See today’s best-performing stocks on TipRanks >>

Read More on CHRS:

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.

Report an Issue